User profiles for C. D. Hinojosa

Chris Hinojosa

Outer Biosciences
Verified email at outerbio.com
Cited by 1599

[HTML][HTML] Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption

…, DV Manatakis, CY Le, CD Hinojosa… - Nature …, 2021 - nature.com
Parkinson’s disease and related synucleinopathies are characterized by the abnormal
accumulation of alpha-synuclein aggregates, loss of dopaminergic neurons, and gliosis of the …

[HTML][HTML] Enhanced utilization of induced pluripotent stem cell–derived human intestinal organoids using microengineered chips

…, EJ Troisi, HQ Estrada, SJ Kerns, CD Hinojosa… - Cellular and molecular …, 2018 - Elsevier
Background and Aims Human intestinal organoids derived from induced pluripotent stem
cells have tremendous potential to elucidate the intestinal epithelium’s role in health and …

[PDF][PDF] Human intestinal morphogenesis controlled by transepithelial morphogen gradient and flow-dependent physical cues in a microengineered gut-on-a-chip

W Shin, CD Hinojosa, DE Ingber, HJ Kim - IScience, 2019 - cell.com
We leveraged a human gut-on-a-chip (Gut Chip) microdevice that enables independent control
of fluid flow and mechanical deformations to explore how physical cues and morphogen …

Organs‐on‐chips in clinical pharmacology: putting the patient into the Center of Treatment Selection and Drug Development

RW Peck, CD Hinojosa… - Clinical Pharmacology & …, 2020 - Wiley Online Library
Hinojosa are employees of and shareholders in Emulate, Inc. As an Associate Editor for
Clinical Pharmacology & Therapeutics, Richard Peck was not involved in the review or decision …

A novel organ-chip system emulates three-dimensional architecture of the human epithelia and the mechanical forces acting on it

…, A Gravanis, GA Hamilton, K Karalis, CD Hinojosa - Biomaterials, 2021 - Elsevier
Successful translation of in vivo experimental data to human patients is an unmet need and
a bottleneck in the development of effective therapeutics. Organ-on-Chip technology aims to …

[PDF][PDF] A microengineered Brain-Chip to model neuroinflammation in humans

…, L Ewart, LL Rubin, ES Manolakos, CD Hinojosa… - Iscience, 2022 - cell.com
Species differences in brain and blood–brain barrier (BBB) biology hamper the translation of
findings from animal models to humans, impeding the development of therapeutics for brain …

Modeling Alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption in Parkinson's disease

I Pediaditakis, KR Kodella, DV Manatakis, CD Hinojosa… - BioRxiv, 2020 - biorxiv.org
Parkinson’s disease and related synucleinopathies are characterized by the abnormal
accumulation of alpha-synuclein aggregates, loss of dopaminergic neurons, and gliosis in the …

A novel Organ-Chip system emulates three-dimensional architecture of the human epithelia and allows fine control of mechanical forces acting on it.

…, A Gravanis, GA Hamilton, KC Karalis, CD Hinojosa - bioRxiv, 2020 - biorxiv.org
Successful translation of in vivo experimental data to human patients is an unmet need and
a bottleneck in the development of effective therapeutics. micro technology aims to address …

Toxicity of cadmium in musculoskeletal diseases

D Reyes-Hinojosa, CA Lozada-Pérez… - Environmental …, 2019 - Elsevier
… Epidemiological studies have reported that exposure to toxic metals like cadmium (Cd)
may … of inflammation and oxidative stress activated by Cd at the bone level, particularly in …

Cadmium distribution in soils covering Jurassic oolitic limestone with high Cd contents in the Swiss Jura

RP Quezada-Hinojosa, V Matera, T Adatte… - Geoderma, 2009 - Elsevier
Oolitic carbonates belonging to the Hauptrogenstein Formation of Bajocian (Middle Jurassic)
age have been shown to be anomalously enriched in cadmium (Cd) throughout the Jura …